How to estimate the value of a technology in a specific marketplace is a complex issue.


We consider the technology assets as a bundling of know-how and IP-related specific assets (patent, copyright, trade secret). The valuation process requires indeed deep expertise, appropriate methodologies and advanced Competitive Technology Intelligence capabilities.


A technology bundle can either be referred to a single patent or to a family of patents, products, processes and technical know-how.


The successful development of any new technology requires a combination of technological, finance and management skills. ICM Advisors  provides advisory and research services to design and develop technology valorization and monetization programmes on behalf of clients in the private and public sectors, including economic development agencies, research establishments and academic institutions.

From the customer point of view, our Technology Value Management (TVM©) service gives management answers to the following issues:

  • What advances are being made in our core technologies?
  • What capabilities do our competitors have and how might they use them against us?
  • Which of our key technologies are maturing and what will replace them?
  • Are we about to be blind-sided? By whom? When? How?
  • Who is working on technologies that could benefit us, and how might we access them?
  • In short, where do we need to focus our technology investments to achieve competitive success?

We have an extensive network of Technology Experts able to deeply understand and assess specific technologies in many products/applications. Our valuation professionals have technical degrees.

We understand the science behind the technology to provide an opinion with greater precision.

We consider all the factors that affect value including useful life, product life on the shelf, price and market demand, and general due diligence.

We go straight to the source by interviewing patent owners and inventors.

Read Valuation Services Brochure



In order to valuate technologies and patents ICM Advisors has developed a specific methodology TES© - (Technology Equity Score) that analyzes and assesses 32 metrics elements in 6 areas

  • role of the technology in the market/product segment
  • life cycle postioning
  • quality and asset risk
  • business impact (cost, volume, market share)
  • legal and management status
  • potential in use or exploitation in other markets/applications

In doing so, ICM Advisors leverages its experience in market and industry analysis, technical and competitive intelligence research and market economics in order to provide documented valuation of intellectual property, from single patents to entire portfolios. Valuations are used in capital development, debt financing, asset management, and intellectual property holding design.




ICM Advisors deals with the valuation experience of other identifiable intangibles assets such as: Proprietary know-how & Trade Secret, Copyrights, Industrial Design, R&D projects and Contract-Related intangibles (franchises, licensing agreements, construction permits, broadcast rights, and service or supply contracts).



Trade secrets are both valuable as patent alternatives and patent complementaries.

They are proprietary information, knowledge, formulas, methods, designs or processes.

What differentiates trade secrets from know-how is that they must present a commercial advantage, they are not commercially known or readily ascertainable, they are subject of efforts to keep such knowledge secret.

We have developed and practiced a specific methodology to valuate the Proprietary Know-how

KES© – (Know-how Equity Score).



Industrial design impacts on the brand value of many consumers and semidurable products such as automobiles, furniture, white goods, mobile phones, consumer electronics, tablets.


Through its DES© (Design Equity Score) methodology we valuate the economic and financial contribution of the Industrial Design to the Brand value.




In R&D there are cases when it may be favorable for an enterprise to collaborate with a company, university or some other organizations or consortia.


To successfully achieve R&D collaboration, the organization must manage many business processes, risks, controls and all the other issues involved. If an enterprise does not manage these issues, the collaboration may bring many drawbacks, including significant economic losses.


One of the key issues of Collaborative R&D is to valuate the potential IP Fall out and manage the ownership of the generated assets.


ICM has developed a significant know-how in working with industrial clusters that manage Collaborative R&D projects portfolio. To valuate R&D projects we have developed PES© (Project Equity Score) methodology that measures 27 elements in 5 areas: Probability of Technology success, Technology transferability level, Probability of commercial success, Business Impact, Forward IP.



In-process research and development is a complicated concept, that deserves a high level of attention from companies and investors.


In-process research and development (IPR&D) activities can have significant value and drive a

significant component of the acquisition price of companies, particularly in the software, technology, pharmaceutical and life sciences industries.


IPR&D refers to an intangible asset used in R&D activities and is distinguished from a tangible asset thatis used in R&D activities (e.g. laboratory equipment) or an intangible asset resulting from completed projects R&D.


We support companies and investors to understand the issues and rules relating to in-process research and development expenses in order have a sound valuation for investment decisions.